167 related articles for article (PubMed ID: 2507341)
21. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
[TBL] [Abstract][Full Text] [Related]
22. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
[TBL] [Abstract][Full Text] [Related]
23. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
Robison WG; Tillis TN; Laver N; Kinoshita JH
Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
[TBL] [Abstract][Full Text] [Related]
24. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
25. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
26. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
27. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
28. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
[TBL] [Abstract][Full Text] [Related]
29. [Ciliary body changes associate with aldose reductase in galactosemic rats].
Ikebe H; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1989 Jul; 93(7):758-62. PubMed ID: 2514592
[TBL] [Abstract][Full Text] [Related]
30. Aldose reductase in diabetic complications of the eye.
Kinoshita JH; Fukushi S; Kador P; Merola LO
Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
[TBL] [Abstract][Full Text] [Related]
31. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
32. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
Robison WG; Laver NM; Jacot JL; Glover JP
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
[TBL] [Abstract][Full Text] [Related]
33. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
Yue DK; Hanwell MA; Satchell PM; Turtle JR
Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
[TBL] [Abstract][Full Text] [Related]
34. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
35. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
36. The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576.
Lou MF; Dickerson JE; Chandler ML; Brazzell RK; York BM
J Ocul Pharmacol; 1989; 5(3):233-40. PubMed ID: 2516529
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of aldose reductase from human retina.
Poulsom R
Curr Eye Res; 1987 Mar; 6(3):427-32. PubMed ID: 3107906
[TBL] [Abstract][Full Text] [Related]
38. Aldose reductase expression in human diabetic retina and retinal pigment epithelium.
Vinores SA; Campochiaro PA; Williams EH; May EE; Green WR; Sorenson RL
Diabetes; 1988 Dec; 37(12):1658-64. PubMed ID: 3142801
[TBL] [Abstract][Full Text] [Related]
39. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
40. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
Unakar NJ; Tsui JY; Johnson MJ
Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
